| 2022 | | Publisher Correction: Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2018 | | Pulmonary Hypertension in Connective Tissue Disease is Associated with the New York Heart Association Functional Class and Forced Vital Capacity, But Not with Interstitial Lung Disease | 김현아, 서창희, 정주양 |
| 2008 | | Pulmonary manifestations in connective tissue disease | 서창희 |
| 2004 | | Pure red cell aplasia and adult-onset Still's disease. | 박해심, 서창희, 조성란 |
| 2018 | | Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis | 서창희 |
| 2015 | | Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. | 김현아, 서창희, 정주양 |
| 2021 | | Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review | 김지원, 서창희, 정주양 |
| 2011 | | Replicated association of a regulatory polymorphism in the interferon γ gene with lupus susceptibility. | 서창희 |
| 2020 | | Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry | 김현아 |
| 2020 | | Retention rate and long-term safety of biosimilar CT-P13 in patients with ankylosing spondylitis: data from the Korean College of Rheumatology Biologics registry | 김현아 |
| 2023 | | Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry | 김현아 |
| 2015 | | Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines. | 서창희 |
| 2005 | | Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. | 남동호, 박해심, 서창희, 조재현 |
| 2019 | | Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2022 | | Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis | 서창희 |
| 2015 | | Role of bone scan in the assessment of polymyositis/dermatomyositis. | 김현아, 서창희, 안영실, 정주양 |
| 2024 | | Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren’s syndrome | 김지원, 김현아, 서창희, 정주양, 한재호 |
| 2020 | | Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Rosuvastatin treatment alone cannot alleviate lupus in murine model: A pilot study | 서창희 |
| 2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
| 2016 | | Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research | 서창희, 정주양 |
| 2021 | | Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review | 김지원, 김현아, 서창희, 정주양 |
| 2016 | | Salivary cortisol levels, but not salivary alpha-amylase levels, are elevated in patients with rheumatoid arthritis irrespective of depression | 김현아, 박샛별, 서창희 |
| 2014 | | Salivary gland scintigraphy in Sjögren's syndrome. Comparison of the diagnostic performance of visual and semiquantitative analysis. | 김현아, 서창희, 안영실, 윤준기, 이수진 |
| 2021 | | Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2018 | | SAT0186: Treatment response of intravenous tocilizumab in patients with rheumatoid arthritis based on the level of prior exposure to biologic therapy: results from the kobio | 김현아 |
| 2018 | | SAT0279: Comparison of retention rates between tumour necrosis factor-Α inhibitors in ankylosing spondylitis patients: data from the korean college of rheumatology biologics registry | 김현아 |
| 2018 | | SAT0286: Retention rate and safety data of biosimilar ct-p13 in ankylosing spondylitis patients: data from the korean college of rheumatology biologics registry | 김현아 |
| 2020 | | Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea | 김현아, 서창희, 정주양 |
| 2020 | | SEASONAL VARIATIONS AND ASSOCIATED FACTORS OF GOUT ATTACKS: A PROSPECTIVE MULTICENTER STUDY IN SOUTH KOREA | 김현아, 서창희, 정주양 |
| 2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2015 | | Seasonality of gout in Korea: a multicenter study. | 김현아, 서창희 |
| 2002 | | Sensitization rate of Trichophyton spp. allergen in various allergic diseases and identification of its allergens with immunoblotting | 김선신, 김현아, 남동호, 박해심, 최정희 |
| 2003 | | Serum cytokine profiles in patients with adult onset Still's disease. | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2013 | | Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. | 김현아, 서창희, 전자영, 정주양 |
| 2014 | | Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease. | 김현아, 서창희, 전자영, 정주양 |
| 2017 | | Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2014 | | Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. | 김현아, 서창희, 전자영, 정주양 |
| 2012 | | Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease | 김현아, 서창희, 전자영 |
| 2004 | | Serum Specific IgE to Staphylococcal Superantigens in Sera of ASA-intolerant Asthma | 남동호, 박해심, 서창희 |
| 2016 | | Severity of fibromyalgia symptoms is associated with socioeconomic status and not obesity in Korean patients | 김현아 |
| 2022 | | Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus | 김지원, 김현아, 서창희, 정주양 |
| 2020 | | Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity | 서창희 |
| 2002 | | Skin reactivity and specific IgE sensitization to Tetranychus urticae and identification of IgE binding components | 김현아, 박해심, 최정희 |
| 2011 | | Smoking habits influence pain and functional and psychiatric features in fibromyalgia. | 김현아 |
| 2024 | | Soluble programmed death-1 is a useful indicator for mortality in patients with adult-onset Still's disease | 김현아 |
| 2003 | | Specific IgE determination to shrimp (Metapenaeus joyneri) and identification of its allergen | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2004 | | Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma. | 김승현, 김현준, 남동호, 박해심, 서창희 |
